(The Guardian) – British patients will be the first in the world to receive a pioneering cell therapy that scientists hope will transform the treatment of lung cancer. The treatment uses stem cells taken from bone marrow that have been genetically modified to find and destroy cancer cells. If successful, the treatment would offer hope to lung cancer patients, who continue to face one of the worst outlooks of all cancer patients. More than 40,000 people are diagnosed with the disease in the UK each year and only 5% of patients survive beyond 10 years.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.